Evidence map›Paper›PMID 36870878›Full record

ArticleVaccine2023

Placing a value on increased flexible vaccine manufacturing capacity for future pandemics.

Anthony T Newall, Philippe Beutels, Zoltán Kis, Adrian Towse, Mark Jit

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anthony T NewallSchool of Population Health, Faculty of Medicine, UNSW Sydney, Australia. Electronic address: a.newall@unsw.edu.au.
Philippe BeutelsSchool of Population Health, Faculty of Medicine, UNSW Sydney, Australia; Centre for Health Economics Research & Modelling Infectious Diseases, Vaccine & Infectious Disease Institute, University of Antwerp, Belgium.
Zoltán KisThe Sargent Centre for Process Systems Engineering, Department of Chemical Engineering, Faculty of Engineering, Imperial College London, London, UK; Department of Chemical and Biological Engineering, The University of Sheffield, Sheffield, UK.
Adrian TowseOffice of Health Economics, London, UK.
Mark JitDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; School of Public Health, University of Hong Kong, Hong Kong Special Administrative Region.

Funding

Department of Health HPRU-2019-NIHR200908
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Influenza VaccinesPandemicsInfluenza Vaccines

Identifiers

PMID36870878
PMCPMC9978930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.